XML 57 R44.htm IDEA: XBRL DOCUMENT v3.25.4
Stockholders' Equity (Tables)
12 Months Ended
Jan. 02, 2026
Stockholders' Equity Note [Abstract]  
Schedule of Share-based Compensation, Fair Value of Stock-Based Compensation Granted

The following table represents the fair value of stock-based compensation granted during the year ended 2025 (in thousands):

 

 

 

Fair Value

 

Stock options

 

$

1,214

 

RSUs

 

 

22,560

 

PSUs

 

 

14,463

 

Total stock-based compensation expense

 

$

38,237

 

Schedule of Compensation Cost

The Company recorded stock-based compensation expense by award as follows (in thousands):

 

 

 

Years Ended

 

 

 

2025

 

 

2024

 

 

2023

 

Employee stock options

 

$

7,190

 

 

$

13,824

 

 

$

12,842

 

Restricted stock

 

 

302

 

 

 

512

 

 

 

548

 

RSUs

 

 

13,382

 

 

 

11,623

 

 

 

7,213

 

PSUs

 

 

7,645

 

 

 

568

 

 

 

1,270

 

Nonemployee stock options

 

 

553

 

 

 

567

 

 

 

869

 

Nonemployee RSUs

 

 

1,516

 

 

 

116

 

 

 

774

 

Total stock-based compensation expense

 

$

30,588

 

 

$

27,210

 

 

$

23,516

 

Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs

The Company recorded stock-based compensation expense in the following categories (in thousands):

 

 

 

Years Ended

 

 

 

2025

 

 

2024

 

 

2023

 

Cost of sales

 

$

665

 

 

$

1,192

 

 

$

716

 

General and administrative

 

 

17,615

 

 

 

14,122

 

 

 

12,125

 

Selling and marketing

 

 

5,306

 

 

 

4,583

 

 

 

4,083

 

Research and development

 

 

7,002

 

 

 

7,313

 

 

 

6,592

 

Total stock-based compensation expense, net

 

 

30,588

 

 

 

27,210

 

 

 

23,516

 

Amounts capitalized as part of inventory

 

 

702

 

 

 

1,408

 

 

 

1,672

 

Total stock-based compensation expense, gross

 

$

31,290

 

 

$

28,618

 

 

$

25,188

 

 

Schedule of Unrecognized Compensation Cost, Non-Vested Stock-Based Compensation Arrangements

As of January 2, 2026, total unrecognized compensation cost related to non-vested stock-based compensation arrangements granted under the Equity Plan were as follows (in thousands):

 

 

 

2025

 

Stock options

 

$

5,068

 

Restricted stock, RSUs and PSUs

 

 

26,848

 

Total unrecognized stock-based compensation cost

 

$

31,916

 

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions The risk-free rate is based on the U.S. Treasury yield curve corresponding to the expected term at the time of the grant.

 

 

Years Ended

 

 

 

2025

 

 

2024

 

 

2023

 

Expected dividend yield

 

 

0

%

 

 

0

%

 

 

0

%

Expected volatility

 

 

60

%

 

 

59

%

 

 

60

%

Risk-free interest rate

 

 

4.07

%

 

 

4.17

%

 

 

3.98

%

Expected term (in years)

 

 

5.05

 

 

 

5.29

 

 

 

5.05

 

Schedule of Share-based Compensation, Stock Options, Activity

A summary of stock option activity under the Equity Plan for the year ended January 2, 2026 was as follows:

 

 

 

Shares
(in 000’s)

 

 

Weighted-Average Exercise Price

 

 

Weighted-Average Remaining Contractual Term (years)

 

 

Aggregate Intrinsic Value (in 000’s)

 

Outstanding at December 27, 2024

 

 

2,808

 

 

$

45.72

 

 

 

 

 

 

 

Granted

 

 

121

 

 

 

18.22

 

 

 

 

 

 

 

Exercised

 

 

(221

)

 

 

15.66

 

 

 

 

 

 

 

Forfeited or expired

 

 

(992

)

 

 

50.48

 

 

 

 

 

 

 

Outstanding at January 2, 2026

 

 

1,716

 

 

$

44.85

 

 

 

6.13

 

 

$

2,263

 

Exercisable at January 2, 2026

 

 

1,370

 

 

$

48.02

 

 

 

5.53

 

 

$

1,604

 

Share-based Compensation, Performance Shares Award Unvested Activity

A summary of unvested stock options activity under the Equity Plan for the year ended January 2, 2026 was as follows:

 

 

Shares
(in 000’s)

 

 

Weighted-Average Grant-Date Fair Value

 

Unvested at December 27, 2024

 

 

982

 

 

$

23.62

 

Granted

 

 

121

 

 

 

10.04

 

Forfeited or expired

 

 

(370

)

 

 

24.42

 

Vested

 

 

(387

)

 

 

24.13

 

Unvested at January 2, 2026

 

 

346

 

 

$

17.90

 

Summary of Weighted Average Grant Date Fair Value of Stock Options Granted Under The Equity Plan and Total intrinsic Value of Stock options Exercised

The weighted average grant date fair value of stock options granted under the Equity Plan and the total intrinsic value of stock options exercised were as follows:

 

 

Years Ended

 

 

 

2025

 

 

2024

 

 

2023

 

Weighted-average grant-date fair value

 

$

10.04

 

 

$

21.12

 

 

$

28.36

 

Intrinsic value of options exercised (in thousands)

 

$

2,027

 

 

$

4,150

 

 

$

17,041

 

Schedule of Share-based Compensation, Restricted Stock, RSU and PSU Activity

A summary of restricted stock, RSU and PSU activity under the Equity Plan for the year ended January 2, 2026 was as follows:

 

 

 

Restricted Stock

 

 

Restricted Stock Units

 

 

Performance Stock Units

 

 

 

Units
(in 000’s)

 

 

Weighted-Average Grant-Date Fair Value

 

 

Units
(in 000’s)

 

 

Weighted-Average Grant-Date Fair Value

 

 

Units
(in 000’s)

 

 

Weighted-Average Grant-Date Fair Value

 

Outstanding at December 27, 2024

 

 

16

 

 

$

40.11

 

 

 

695

 

 

$

43.33

 

 

 

406

 

 

$

39.99

 

Granted

 

 

 

 

 

 

 

 

1,281

 

 

 

17.61

 

 

 

849

 

 

 

17.04

 

Vested

 

 

(16

)

 

 

40.11

 

 

 

(321

)

 

 

42.41

 

 

 

(20

)

 

 

74.80

 

Forfeited

 

 

 

 

 

 

 

 

(196

)

 

 

33.48

 

 

 

(433

)

 

 

35.93

 

Outstanding at January 2, 2026

 

 

 

 

$

 

 

 

1,459

 

 

$

22.29

 

 

 

802

 

 

$

17.04

 

Summary of Weighted Average Grant Date Fair Value of Restricted Stock, RSU and PSU Awards Granted Under Equity Plan and Total Fair Value of Awards Vested

The weighted average grant date fair value of restricted stock, RSU and PSU awards granted under the Equity Plan and the total fair value of awards vested were as follows:

 

 

 

Years Ended

 

 

 

2025

 

 

2024

 

 

2023

 

Weighted-average grant-date fair value

 

$

17.38

 

 

$

37.73

 

 

$

52.98

 

Fair value of awards vested (in thousands)

 

$

7,280

 

 

$

6,283

 

 

$

7,715